The global Diagnostic Radiopharmaceuticals market was valued at US$ 3873 million in 2019 and is expected to reach US$ 6121.6 million by the end of 2026, growing at a CAGR of 6.9% during 2021-2026.
Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.
North America is the world’s major consumer region, with sales accounting for 41.59% of the global total in 2019. Europe is also a major consumer region, accounting for 24.5% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.
Global Diagnostic Radiopharmaceuticals Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2016 to 2027. This section mentions the volume of production by region from 2016 to 2027. Pricing analysis is included in the report according to each type from the year 2016 to 2027, manufacturer from 2016 to 2021, region from 2016 to 2021, and global price from 2016 to 2027.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Global Diagnostic Radiopharmaceuticals Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027.
Key Companies profiled in this report are Diagnostic Radiopharmaceuticals market report are Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, Advanced Accelerator Applications, SIEMENS, China Isotope & Radiation, Dongcheng Pharmaceutical Group, Lantheus, Eli Lil and more in terms of market share by sales, revenue, average pricing, product type, margins, recent developments etc.
Segment by Type
- Technetium 99
- Fluorine 18
Segment by Application
Table of Content:
1 Diagnostic Radiopharmaceuticals Market Overview
2 Diagnostic Radiopharmaceuticals Market Competition by Manufacturers
3 Diagnostic Radiopharmaceuticals Retrospective Market Scenario by Region
4 Global Diagnostic Radiopharmaceuticals Historic Market Analysis by Type
5 Global Diagnostic Radiopharmaceuticals Historic Market Analysis by Application
6 Key Companies Profiled
7 Diagnostic Radiopharmaceuticals Manufacturing Cost Analysis
8 Marketing Channel, Distributors and Customers
9 Diagnostic Radiopharmaceuticals Market Dynamics
10 Global Market Forecast
11 Research Finding and Conclusion
12 Methodology and Data Source
Company Name: The Market Reports
Contact Person: Shirish Gupta
Erik Brady is a news media and fitness professional with a strong experience in online journalism as well as he is a well-known fitness instructor. He strength includes knowledge of sports, health, yoga, meditation, and proficiency. From a young age, Erik has interest in Football and he is BundesPremierLeague Contributor.